Chief Financial OfficerCIK 0002037968
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER |  LONALeonaBio, Inc.Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 | |
Renninger RobertCHIEF FINANCIAL OFFICER |
| LONALeonaBio, Inc. Option exercise |
| M |
| — 3,900 sh |
| Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Renninger RobertCHIEF FINANCIAL OFFICER | LONALeonaBio, Inc. Option exercise | M | — 3,900 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 31 | Renninger RobertCHIEF FINANCIAL OFFICER | LONALeonaBio, Inc. Open-market sale | SELL | $4,865 906 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 28 | Renninger RobertChief Financial Officer |  ATHALeonaBio, Inc.Grant or award | A | $2,310 1,000 sh | Jan 5, 2026 traded Nov 18, 2025 |
| 19 | Renninger RobertChief Financial Officer | ATHALeonaBio, Inc. Option exercise | M | — 1,236 sh | Jan 5, 2026 traded Dec 31, 2025 |
| 31 | Renninger RobertChief Financial Officer | ATHALeonaBio, Inc. Open-market sale | SELL | $2,043 297 sh | Jan 5, 2026 traded Jan 2, 2026 |
| 15 | Renninger RobertChief Financial Officer | ATHALeonaBio, Inc. Option exercise | M | — 1,236 sh | Jan 5, 2026 traded Dec 31, 2025 |
| 15 | Renninger RobertChief Financial Officer | ATHALeonaBio, Inc. Grant or award | A | — 34.4K sh | Dec 29, 2025 traded Dec 24, 2025 |